Coaching to help ketamine therapy for hard-to-treat depression
Part of Mental health clinical trials.
This study tests whether adding coaching sessions can help people who are already getting ketamine or esketamine treatment for depression that hasn't responded to other medications. You'd receive weekly coaching calls designed to support your recovery while you continue your regular ketamine clinic visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- At least 18 years old and able to understand and consent to the study
- Fluent in spoken and written English
- Currently in the maintenance phase of ketamine or esketamine treatment (past the initial 2–3 week intensive phase) at Massachusetts General Hospital's Ketamine Clinic
- Have completed at least 3 maintenance treatments before joining, with moderate-to-severe depression symptoms on your most recent treatments
- Have a diagnosis of depression and currently have a mental health provider (therapist, psychiatrist, or counselor)
- Willing to have coaching sessions recorded on a secure video platform
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding a type of talk therapy called integration therapy helps esketamine work better for people with depression that hasn't improved with other treatments. You'll receive esketamine, and some people also get guided sessions to reflect on their experiences.
This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.
This study tests whether ketamine, given with talk therapy, can help people whose depression hasn't improved with at least two antidepressants. It aims to see if this combination can reduce depression symptoms.
This study tests how a single dose of ketamine affects certain brain and body markers in people with severe depression. It aims to find better ways to predict who will respond to ketamine, which may help personalize depression treatment in the future.
This trial tests whether ketamine-assisted group therapy can help Spanish-speaking Latinx adults with major depression. You would receive ketamine in a supportive group setting, with the goal of improving your mood and quality of life.
This Phase 4 study tests whether ongoing treatment with ketamine or esketamine can reduce suicidal thoughts in people with major depression who are at high risk. Because the study focuses on long-term maintenance, you’d receive treatment over time while being closely monitored for safety and mental health changes.
Hear when a new Treatment Resistant Depression (TRD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.